Raises Xtant Medical FY 2026 Revenue Guidance to $101m-$105m as It Adds Hemoblast Distribution Rights

Earnings Call Insights: Xtant Medical Holdings (XTNT) Q1 2026 Management View - "Since our last quarterly update, Xtant Medical has achieved multiple significant milestones that position us for sustained growth," said President, CEO & Director Sean Browne, highlighting: "We...</p

Earnings Call Insights: Xtant Medical Holdings (XTNT) Q1 2026 Management View – “Since our last quarterly update, Xtant Medical has achieved multiple significant milestones that position us for sustained growth,” said President, CEO & Director Sean Browne, highlighting: “We…

rengthened our balance sheet with proceeds from the Companion Seeking Alpha’s Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed

This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank

Leave a Reply

Your email address will not be published. Required fields are marked *